💼 SBI Life Insurance Company Ltd | Mar 2025 Results Out
Mixed Quarter 😐
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹23860.71 Cr
📅 Dec 2024: ₹24827.54 Cr
📅 Mar 2024: ₹25116.47 Cr
📉 🔻3.89% QoQ, 🔻5.00% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹840.61 Cr
📅 Dec 2024: ₹571.61 Cr
📅 Mar 2024: ₹836.35 Cr
📉 ⬆️47.06% QoQ, ⬆️0.51% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹813.51 Cr
📅 Dec 2024: ₹550.82 Cr
📅 Mar 2024: ₹810.80 Cr
📉 ⬆️47.69% QoQ, ⬆️0.33% YoY
🤖 Key Insights:
📌 PAT saw a strong 47.7% QoQ jump to ₹813.5 Cr in Q4 FY25, but this was despite a 3.9% QoQ revenue decline. YoY PAT growth was minimal at 0.3%, while revenue fell 5% YoY. Investment income likely played a role in bolstering profits. 📈
📌 Value of New Business (VNB) for FY25 was reported at ₹59.5 billion, a positive indicator for future profitability, aligning with the company's growth focus. 💰
📌 Persistency remains a strength, with 13th-month ratio at a healthy 87.41% for FY25, showing good customer retention. 👍
📌 Expense of Management ratio increased to 9.68% in FY25 from 8.89% in FY24, highlighting rising operational costs that need monitoring. ⚠️
📌 Fundamentals look solid: Solvency ratio is comfortable at 1.96x, well above the regulatory minimum. Long-term outlook seems positive given under-penetration and brand strength, though short-term headwinds like competition and potential regulatory impacts persist. 🏦
Join us @wealthmantraofficial
Mixed Quarter 😐
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹23860.71 Cr
📅 Dec 2024: ₹24827.54 Cr
📅 Mar 2024: ₹25116.47 Cr
📉 🔻3.89% QoQ, 🔻5.00% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹840.61 Cr
📅 Dec 2024: ₹571.61 Cr
📅 Mar 2024: ₹836.35 Cr
📉 ⬆️47.06% QoQ, ⬆️0.51% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹813.51 Cr
📅 Dec 2024: ₹550.82 Cr
📅 Mar 2024: ₹810.80 Cr
📉 ⬆️47.69% QoQ, ⬆️0.33% YoY
🤖 Key Insights:
📌 PAT saw a strong 47.7% QoQ jump to ₹813.5 Cr in Q4 FY25, but this was despite a 3.9% QoQ revenue decline. YoY PAT growth was minimal at 0.3%, while revenue fell 5% YoY. Investment income likely played a role in bolstering profits. 📈
📌 Value of New Business (VNB) for FY25 was reported at ₹59.5 billion, a positive indicator for future profitability, aligning with the company's growth focus. 💰
📌 Persistency remains a strength, with 13th-month ratio at a healthy 87.41% for FY25, showing good customer retention. 👍
📌 Expense of Management ratio increased to 9.68% in FY25 from 8.89% in FY24, highlighting rising operational costs that need monitoring. ⚠️
📌 Fundamentals look solid: Solvency ratio is comfortable at 1.96x, well above the regulatory minimum. Long-term outlook seems positive given under-penetration and brand strength, though short-term headwinds like competition and potential regulatory impacts persist. 🏦
Join us @wealthmantraofficial
All existing valid visas issued by India to Pakistani nationals stand revoked from April 27
Medical Visas Issued To Pakistani Nationals Will Be Valid Only Till April 29 ; India Official
Medical Visas Issued To Pakistani Nationals Will Be Valid Only Till April 29 ; India Official
💼 Jayshree Chemicals Ltd | Mar 2025 Results Out
Turnaround Signs 👍
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹461.00 Lakh
📅 Dec 2024: ₹339.00 Lakh
📅 Mar 2024: ₹341.00 Lakh
📉 ⬆️35.99% QoQ, ⬆️35.19% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹14.00 Lakh
📅 Dec 2024: ₹-50.00 Lakh
📅 Mar 2024: ₹-346.00 Lakh
📉 ⬆️128.00% QoQ, ⬆️104.05% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹14.00 Lakh
📅 Dec 2024: ₹-50.00 Lakh
📅 Mar 2024: ₹-346.00 Lakh
📉 ⬆️128.00% QoQ, ⬆️104.05% YoY
🤖 Key Insights:
📌 Returned to quarterly profit (₹14 L) after significant prior losses, signaling a potential turnaround driven by the core Trading division's improved performance. 📈
📌 Strategic streamlining achieved via Wind Power divestment and Electric unit closure, sharpening focus purely on the Chemical Trading business. 🎯
📌 Full-year loss reduced considerably for FY25 vs FY24 despite exceptional items, though TTM earnings remain negative (-₹2.28 Cr). 👀
📌 Increased Trade Receivables warrant monitoring alongside revenue growth efforts in the trading segment. ⚠️
📌 Future prospects hinge on sustaining profitability in Chemical Trading; I think the outlook is cautiously optimistic short-term, dependent on execution long-term amidst sector headwinds like input costs. 🏦
Join us @wealthmantraofficial
Turnaround Signs 👍
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹461.00 Lakh
📅 Dec 2024: ₹339.00 Lakh
📅 Mar 2024: ₹341.00 Lakh
📉 ⬆️35.99% QoQ, ⬆️35.19% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹14.00 Lakh
📅 Dec 2024: ₹-50.00 Lakh
📅 Mar 2024: ₹-346.00 Lakh
📉 ⬆️128.00% QoQ, ⬆️104.05% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹14.00 Lakh
📅 Dec 2024: ₹-50.00 Lakh
📅 Mar 2024: ₹-346.00 Lakh
📉 ⬆️128.00% QoQ, ⬆️104.05% YoY
🤖 Key Insights:
📌 Returned to quarterly profit (₹14 L) after significant prior losses, signaling a potential turnaround driven by the core Trading division's improved performance. 📈
📌 Strategic streamlining achieved via Wind Power divestment and Electric unit closure, sharpening focus purely on the Chemical Trading business. 🎯
📌 Full-year loss reduced considerably for FY25 vs FY24 despite exceptional items, though TTM earnings remain negative (-₹2.28 Cr). 👀
📌 Increased Trade Receivables warrant monitoring alongside revenue growth efforts in the trading segment. ⚠️
📌 Future prospects hinge on sustaining profitability in Chemical Trading; I think the outlook is cautiously optimistic short-term, dependent on execution long-term amidst sector headwinds like input costs. 🏦
Join us @wealthmantraofficial
💼 Waaree Technologies Ltd | Mar 2025 Results Out
Weak Results 📉
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹463.95 Lakh
📅 Sep 2024: ₹559.62 Lakh
📅 Mar 2024: ₹1504.94 Lakh
📉 🔻17.10% HoH, 🔻69.17% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹-407.55 Lakh
📅 Sep 2024: ₹-345.71 Lakh
📅 Mar 2024: ₹-722.73 Lakh
📉 🔻17.89% HoH, ⬆️43.61% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹-303.03 Lakh
📅 Sep 2024: ₹-261.97 Lakh
📅 Mar 2024: ₹-550.53 Lakh
📉 🔻15.67% HoH, ⬆️44.96% YoY
🤖 Key Insights:
📌 Persistent losses (-₹303 L PAT in H2 FY25) driven by severe revenue decline (-69% YoY), indicating continued operational struggles. 📉
📌 Deepening negative net worth (-₹191 L) coupled with high short-term debt (~₹1766 L) flags serious financial stability concerns; RoE remains deeply negative. 🏦⚠️
📌 The company's diverse trading activities (tapes, e-vehicles, AI) haven't yet translated into profitability, underscoring the need for a clear turnaround strategy. ❓
📌 Traditional valuation metrics like PE are not applicable due to negative earnings. The stock trades at an extremely high multiple of its book value, placing emphasis on future recovery potential. N/A
📌 While potential macro tailwinds exist, significant internal financial headwinds and inherent SME stock volatility define the current risk profile. 👀
Join us @wealthmantraofficial
Weak Results 📉
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹463.95 Lakh
📅 Sep 2024: ₹559.62 Lakh
📅 Mar 2024: ₹1504.94 Lakh
📉 🔻17.10% HoH, 🔻69.17% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹-407.55 Lakh
📅 Sep 2024: ₹-345.71 Lakh
📅 Mar 2024: ₹-722.73 Lakh
📉 🔻17.89% HoH, ⬆️43.61% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹-303.03 Lakh
📅 Sep 2024: ₹-261.97 Lakh
📅 Mar 2024: ₹-550.53 Lakh
📉 🔻15.67% HoH, ⬆️44.96% YoY
🤖 Key Insights:
📌 Persistent losses (-₹303 L PAT in H2 FY25) driven by severe revenue decline (-69% YoY), indicating continued operational struggles. 📉
📌 Deepening negative net worth (-₹191 L) coupled with high short-term debt (~₹1766 L) flags serious financial stability concerns; RoE remains deeply negative. 🏦⚠️
📌 The company's diverse trading activities (tapes, e-vehicles, AI) haven't yet translated into profitability, underscoring the need for a clear turnaround strategy. ❓
📌 Traditional valuation metrics like PE are not applicable due to negative earnings. The stock trades at an extremely high multiple of its book value, placing emphasis on future recovery potential. N/A
📌 While potential macro tailwinds exist, significant internal financial headwinds and inherent SME stock volatility define the current risk profile. 👀
Join us @wealthmantraofficial
Aimtron Electronics – H2FY25 Results 🚀
SME
H2 FY25 vs H1 FY25
👇👇👇
👉💰 Total Income: ₹102 Cr vs ₹58 Cr (+76.5%)
👉💸 Net Profit: ₹14.55 Cr vs ₹11.18 Cr (+30.1%)
YoY FY25 vs FY24
👇👇👇
👉📈 Total Income: ₹161.23 Cr vs ₹93.72 Cr
👉🤑 Net Profit: ₹25.71 Cr vs ₹13.59 Cr (+89.1%)
👉✨ PAT almost 2x YoY!
Valuation Check:
📊 Market Cap: ~₹1,200 Cr
📈 PE Ratio: ~47
🎯 Management targets 50% CAGR
🚫 No ESM concerns!
✅ Strong growth with solid fundamentals!
Join us @wealthmantraofficial
SME
H2 FY25 vs H1 FY25
👇👇👇
👉💰 Total Income: ₹102 Cr vs ₹58 Cr (+76.5%)
👉💸 Net Profit: ₹14.55 Cr vs ₹11.18 Cr (+30.1%)
YoY FY25 vs FY24
👇👇👇
👉📈 Total Income: ₹161.23 Cr vs ₹93.72 Cr
👉🤑 Net Profit: ₹25.71 Cr vs ₹13.59 Cr (+89.1%)
👉✨ PAT almost 2x YoY!
Valuation Check:
📊 Market Cap: ~₹1,200 Cr
📈 PE Ratio: ~47
🎯 Management targets 50% CAGR
🚫 No ESM concerns!
✅ Strong growth with solid fundamentals!
Join us @wealthmantraofficial
BREAKING: Pakistan says any attempt to 'stop or divert flow of water belonging to Pakistan as per Indus Waters Treaty will be considered as an Act of War'
Cyient FY25 Update:
Mixed Growth, Strong Cash Position & Strategic Wins ⚡ | MCap 13,802.69 Cr
- Group revenue: $870M (+1.5% YoY, constant currency)
- Group PAT: ₹622Cr (-15.4% YoY), EPS: ₹56.50
- Total dividend: ₹26/share (₹14 final dividend)
- DET revenue: $687.7M (-3.0% YoY)
- DET order intake: $836.1M (-7.3% YoY)
- 24 large DET deals won ($370.8M total potential)
- Group FCF: ₹688Cr (+6.2% YoY)
- DET cash position: $157M (debt-free)
- DET attrition: 16.5% (Q4 FY25)
- New subsidiary: Cyient Semiconductors (CEO: Suman Narayan)
- New CEO for Cyient DET: Sukamal Banerjee
- Strategic hydrogen project in Norway
- Alliance with Micware Navigations for mobility solutions
Join us @wealthmantraofficial
Mixed Growth, Strong Cash Position & Strategic Wins ⚡ | MCap 13,802.69 Cr
- Group revenue: $870M (+1.5% YoY, constant currency)
- Group PAT: ₹622Cr (-15.4% YoY), EPS: ₹56.50
- Total dividend: ₹26/share (₹14 final dividend)
- DET revenue: $687.7M (-3.0% YoY)
- DET order intake: $836.1M (-7.3% YoY)
- 24 large DET deals won ($370.8M total potential)
- Group FCF: ₹688Cr (+6.2% YoY)
- DET cash position: $157M (debt-free)
- DET attrition: 16.5% (Q4 FY25)
- New subsidiary: Cyient Semiconductors (CEO: Suman Narayan)
- New CEO for Cyient DET: Sukamal Banerjee
- Strategic hydrogen project in Norway
- Alliance with Micware Navigations for mobility solutions
Join us @wealthmantraofficial
💼 Cyient Ltd | Mar 2025 Results Out
Mixed Quarter; Decent Recovery 👍
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹1909.20 Cr
📅 Dec 2024: ₹1926.40 Cr
📅 Mar 2024: ₹1860.80 Cr
📉 🔻0.89% QoQ, ⬆️2.60% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹252.50 Cr
📅 Dec 2024: ₹173.60 Cr
📅 Mar 2024: ₹259.10 Cr
📉 ⬆️45.45% QoQ, 🔻2.55% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹170.40 Cr
📅 Dec 2024: ₹122.30 Cr
📅 Mar 2024: ₹189.20 Cr
📉 ⬆️39.33% QoQ, 🔻9.94% YoY
🤖 Key Insights:
📌 Q4 PAT showed a strong sequential jump (+39.3%) mainly due to the high-growth DLM segment, but declined YoY (-9.9%) dragged by continued softness in the larger Digital, Engineering & Technology (DET) business. FY25 performance reflects this divergence.
📌 The company significantly missed its initial FY25 guidance, revising revenue growth downwards multiple times to a -2.7% contraction and cutting the exit margin target sharply. Achieving the stated FY26 margin goal of 16% appears challenging given the weak FY25 exit rate. 👀
📌 Strategic moves like the semiconductor business carve-out and recent acquisitions are positive steps towards higher growth areas, but integration success and turning acquired entities profitable are crucial monitorables. 🏗️💰
📌 The current TTM PE of around 22x seems lower compared to previous levels, potentially reflecting concerns about DET segment recovery and recent guidance cuts. Valuation hinges on renewed growth momentum. 📉
📌 While the long-term outlook benefits from digital engineering tailwinds, near-term challenges include reviving the core DET business amidst global uncertainties and managing the impact of the recent fair value reduction in an investment. 🏦⚠️
Join us @wealthmantraofficial
Mixed Quarter; Decent Recovery 👍
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹1909.20 Cr
📅 Dec 2024: ₹1926.40 Cr
📅 Mar 2024: ₹1860.80 Cr
📉 🔻0.89% QoQ, ⬆️2.60% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹252.50 Cr
📅 Dec 2024: ₹173.60 Cr
📅 Mar 2024: ₹259.10 Cr
📉 ⬆️45.45% QoQ, 🔻2.55% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹170.40 Cr
📅 Dec 2024: ₹122.30 Cr
📅 Mar 2024: ₹189.20 Cr
📉 ⬆️39.33% QoQ, 🔻9.94% YoY
🤖 Key Insights:
📌 Q4 PAT showed a strong sequential jump (+39.3%) mainly due to the high-growth DLM segment, but declined YoY (-9.9%) dragged by continued softness in the larger Digital, Engineering & Technology (DET) business. FY25 performance reflects this divergence.
📌 The company significantly missed its initial FY25 guidance, revising revenue growth downwards multiple times to a -2.7% contraction and cutting the exit margin target sharply. Achieving the stated FY26 margin goal of 16% appears challenging given the weak FY25 exit rate. 👀
📌 Strategic moves like the semiconductor business carve-out and recent acquisitions are positive steps towards higher growth areas, but integration success and turning acquired entities profitable are crucial monitorables. 🏗️💰
📌 The current TTM PE of around 22x seems lower compared to previous levels, potentially reflecting concerns about DET segment recovery and recent guidance cuts. Valuation hinges on renewed growth momentum. 📉
📌 While the long-term outlook benefits from digital engineering tailwinds, near-term challenges include reviving the core DET business amidst global uncertainties and managing the impact of the recent fair value reduction in an investment. 🏦⚠️
Join us @wealthmantraofficial
CYIENT Q4 CONS:
NET PROFIT UP 39% AT 170.4 CR (QOQ) , DOWN 9.9% (YOY)
REVENUE DOWN 1% AT 1909.2 CR (QOQ) , UP 2.6% (YOY)
EBIT UP 11% AT 234.8CR (QOQ) , DOWN 12 % (YOY)
MARGINS AT 12.29 % V 10.9 % (QOQ) , 14.4 % (YOY)
CO DECLARE DIVIDEND 14 RS PER SHARE
Join us @wealthmantraofficial
NET PROFIT UP 39% AT 170.4 CR (QOQ) , DOWN 9.9% (YOY)
REVENUE DOWN 1% AT 1909.2 CR (QOQ) , UP 2.6% (YOY)
EBIT UP 11% AT 234.8CR (QOQ) , DOWN 12 % (YOY)
MARGINS AT 12.29 % V 10.9 % (QOQ) , 14.4 % (YOY)
CO DECLARE DIVIDEND 14 RS PER SHARE
Join us @wealthmantraofficial
💼 AAVAS Financiers Ltd | Mar 2025 Results Out
Solid FY24 Performance, Q4 tempered by costs 👍
Net Profit Up 7.8% At ₹153.7 Cr Vs ₹142.6 Cr (YoY)
NII Up 14.5% At ₹371.5 Cr Vs ₹324.4 Cr (YoY)
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹636.21 Cr
📅 Dec 2024: ₹596.74 Cr
📅 Mar 2024: ₹546.02 Cr
📉 ⬆️6.61% QoQ, ⬆️16.52% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹193.22 Cr
📅 Dec 2024: ₹188.40 Cr
📅 Mar 2024: ₹177.49 Cr
📉 ⬆️2.56% QoQ, ⬆️8.86% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹153.68 Cr
📅 Dec 2024: ₹146.42 Cr
📅 Mar 2024: ₹142.62 Cr
📉 ⬆️4.96% QoQ, ⬆️7.76% YoY
🤖 Key Insights:
📌 Aavas reported robust FY24 PAT growth around 14%, though Q4 PAT growth (~8% YoY) was impacted by higher operating costs, especially employee expenses (+23% QoQ), somewhat limiting margin expansion despite strong NII. 👍
📌 Management guidance for FY25 AUM growth is 20-25%, supported by record Q4 disbursements (+39% QoQ). Maintaining spreads around 5% and managing costs will be crucial for achieving profitability targets. 🎯
📌 Asset quality remains a key strength (GNPA 0.94% end-FY24, slightly up QoQ to 1.14% in Dec'24 due to seasonality but still healthy). This provides resilience. Long-term outlook is positive due to strong affordable housing demand, though rising competition is a factor. ✅🏦
📌 The current TTM PE of ~29.8x is below the 5-year historical average (around 42x), suggesting a more reasonable valuation currently. The PEG ratio around 1.3 indicates valuation relative to past growth (5yr PAT CAGR ~23%). 👀
📌 Strong capitalization (CRAR ~44% end-FY24) and diversified funding, including the recent NCD raise plans, position the company well to fund future growth in the under-penetrated affordable housing market. 🏗️💰
Join us @wealthmantraofficial
Solid FY24 Performance, Q4 tempered by costs 👍
Net Profit Up 7.8% At ₹153.7 Cr Vs ₹142.6 Cr (YoY)
NII Up 14.5% At ₹371.5 Cr Vs ₹324.4 Cr (YoY)
📊 Key Metrics
Revenue (REV):
📅 Mar 2025: ₹636.21 Cr
📅 Dec 2024: ₹596.74 Cr
📅 Mar 2024: ₹546.02 Cr
📉 ⬆️6.61% QoQ, ⬆️16.52% YoY
Profit Before Tax (PBT):
📅 Mar 2025: ₹193.22 Cr
📅 Dec 2024: ₹188.40 Cr
📅 Mar 2024: ₹177.49 Cr
📉 ⬆️2.56% QoQ, ⬆️8.86% YoY
Profit After Tax (PAT):
📅 Mar 2025: ₹153.68 Cr
📅 Dec 2024: ₹146.42 Cr
📅 Mar 2024: ₹142.62 Cr
📉 ⬆️4.96% QoQ, ⬆️7.76% YoY
🤖 Key Insights:
📌 Aavas reported robust FY24 PAT growth around 14%, though Q4 PAT growth (~8% YoY) was impacted by higher operating costs, especially employee expenses (+23% QoQ), somewhat limiting margin expansion despite strong NII. 👍
📌 Management guidance for FY25 AUM growth is 20-25%, supported by record Q4 disbursements (+39% QoQ). Maintaining spreads around 5% and managing costs will be crucial for achieving profitability targets. 🎯
📌 Asset quality remains a key strength (GNPA 0.94% end-FY24, slightly up QoQ to 1.14% in Dec'24 due to seasonality but still healthy). This provides resilience. Long-term outlook is positive due to strong affordable housing demand, though rising competition is a factor. ✅🏦
📌 The current TTM PE of ~29.8x is below the 5-year historical average (around 42x), suggesting a more reasonable valuation currently. The PEG ratio around 1.3 indicates valuation relative to past growth (5yr PAT CAGR ~23%). 👀
📌 Strong capitalization (CRAR ~44% end-FY24) and diversified funding, including the recent NCD raise plans, position the company well to fund future growth in the under-penetrated affordable housing market. 🏗️💰
Join us @wealthmantraofficial
Tech Mahindra reports #Q4 earnings
--Net Profit Up 18.7% At ₹1,166.7 Cr Vs ₹983.2 Cr (QoQ)
--Revenue Up 0.7% At ₹13,384 Cr vs ₹13,285.6 Cr (QoQ)
--EBITDA Up 2.1% At ₹1,378 Cr Vs ₹1,350.2 Cr (QoQ)
--Margin At 10.3% Vs 10.2% (QoQ)
Join us @wealthmantraofficial
--Net Profit Up 18.7% At ₹1,166.7 Cr Vs ₹983.2 Cr (QoQ)
--Revenue Up 0.7% At ₹13,384 Cr vs ₹13,285.6 Cr (QoQ)
--EBITDA Up 2.1% At ₹1,378 Cr Vs ₹1,350.2 Cr (QoQ)
--Margin At 10.3% Vs 10.2% (QoQ)
Join us @wealthmantraofficial